One drawback  StrictionD Review that concerns critics with regard to the artificial pancreas is that it places glucose-monitoring, administration of insulin, completely within the device's control and takes it away from doctor/nurse monitoring. However, supporters of the device, the JDRF, Juvenile Diabetes Research Foundation, has been working closely with the FDA to get the device released sooner than later, citing that the United States is already 3 years behind other countries in the consumer use of the device.

https://supplementlegend.com/strictiond-review/